Sunresin and ChiralVision sign a collaboration agreement for the development of immobilized enzymes for applications in pharma, food and fine chemistry.
Dr. Rob Schoevaart, Managing Director of ChiralVision, comments “We have been successful in the market for more than 18 years with our expertise in enzymatic process development using tailored immobilized biocatalysts. Enzyme immobilization is the key to economical and sustainable production. Through the collaboration with Sunresin who is one of the biggest and most innovative resin manufacturer in the world we can now support much larger and more complex development projects and let our commercial scale production of immobilized enzymes grow further. We are eager to take this step and consolidate the current partnership.”
Dr. Alessandra Basso, Global Sales and Marketing Director Life Science, comments “I am very happy to start a long term collaboration with Chiralvision. Chiralvision has a great knowledge in the development of immobilized enzymes and has a strong reputation in the market. By combining Chiralvision expertise and Sunresin portfolio of resins for enzyme immobilization we can offer our customers solutions for a faster implementation of immobilized enzymes in their processes. We are ready to support Chiralvision with standard resins for enzyme immobilization and customized resins for the fast delivery of biocatalysts to the market. ”
